Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2017 05:30 ET | Source: TiGenix

TiGenix opens US headquarters in Cambridge, MA

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix opens US...
June 23, 2017 01:00 ET | Source: TiGenix

Présentation de TiGenix à l'occasion de la 7ème Conférence TERMIS-UE à Davos (Suisse)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE Présentation de...
June 23, 2017 01:00 ET | Source: TiGenix

Presentatie van TiGenix op de 7de TERMIS-EU Conference in Davos, Zwitserland

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PERSBERICHT Presentatie van TiGenix...
June 23, 2017 01:00 ET | Source: TiGenix

TiGenix to present at the 7th TERMIS-EU Conference in Davos, Switzerland

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix to present at...
June 20, 2017 01:00 ET | Source: TiGenix

Takeda et TiGenix annoncent que Swissmedic a accepté la demande d'évaluation relative au Cx106 pour le traitement des fistules périanales complexes chez les patients atteints de la maladie de Crohn.

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE Takeda et TiGenix...
June 20, 2017 01:00 ET | Source: TiGenix

Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE Takeda and TiGenix...
June 20, 2017 01:00 ET | Source: TiGenix

Takeda en TiGenix kondigen aan dat Swissmedic het dossier van Cx601 voor de behandeling van complexe perianale fistels bij patiënten met de ziekte van Crohn aanvaard heeft voor onderzoek

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PERSBERICHT Takeda en TiGenix...
June 15, 2017 01:00 ET | Source: TiGenix

TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix Partners with...
June 15, 2017 01:00 ET | Source: TiGenix

TiGenix gaat samenwerken met Amerikaanse en Europese patiëntenbelangengroepen die gericht zijn op de ziekte van Crohn en colitis ulcerosa

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PERSBERICHT TiGenix gaat samenwerken...
June 13, 2017 01:00 ET | Source: TiGenix

TiGenix Launches Global Phase III Trial for Cx601

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix Launches Global...